PTX-100 and 200 are good projects as novel agents, hopefully get some results happening from the respective trials.
The kinase inhibitor field is very saturated with dozens of drugs in development for various conditions mind you.
CAR-T is the most exciting project in the portfolio. Hopefully this is the company/fortune maker for long term holders.
We use CAR-Ts in some of our patients are it's definitely going to be a huge part of the future for haematological malignancies and for solid organ cancers. Immunotherapy has been a game changer for cancer treatments and CAR-T is the Ferrari (or maybe Lambo or McLaren) of using the immune system to fight back against cancers....
Ann: PTX announces 3 next-gen CAR-T programs with OmniCAR, page-99
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.001(2.17%) |
Mkt cap ! $36.23M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.5¢ | $26.66K | 576.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 219999 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 114091 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PTX (ASX) Chart |